QA: ARTELO BIOSCIENCES INC. in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001621221_2019_ARTELO_BIOSCIENCES_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001621221')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001621221, ARTELO BIOSCIENCES INC.

  xvar xval
0 AssetsCurrent 396,435
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 563
3 remainder_Assets 0
4 LiabilitiesCurrent 531,972
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 508,278
9 ResearchAndDevelopmentExpense 1,249,854
10 remainder_Expenses 585,359
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -12,937
  yvar yval
0 Assets 396,998
1 Liabilities 531,972
2 Expenses 2,343,491
3 Revenues 0
4 StockholdersEquity -134,974
5 NetIncome -2,343,491
6 ComprehensiveNetIncome -2,349,960
7 BaseVar 1,642,699
8 EconomicCapitalRatio -5.56

Edgar->Model Mapping

Feature Distribution

Change over Time